tiprankstipranks
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market
SLDB
Solid Biosciences
RESEARCH TOOLSreports

Solid Biosciences (SLDB) Financial Statements

Compare
1,584 Followers

Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently $711.37M. The company's EPS TTM is $-0.53; its P/E ratio is -2.83; Solid Biosciences is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 8.09M$ 13.62M
Gross Profit$ -1.64M$ -2.46M$ -2.58M$ 8.09M$ 13.62M
Operating Income$ -179.21M$ -129.73M$ -104.31M$ -106.45M$ -72.25M
EBITDA$ -177.57M$ -121.90M$ -93.43M$ -96.87M$ -69.29M
Net Income$ -174.32M$ -124.70M$ -96.02M$ -85.98M$ -72.19M
Balance Sheet
Cash & Short-Term Investments$ 187.85M$ 148.92M$ 123.64M$ 213.72M$ 207.78M
Total Assets$ 232.54M$ 188.66M$ 164.94M$ 260.25M$ 232.38M
Total Debt$ 21.16M$ 24.18M$ 26.27M$ 28.55M$ 2.06M
Net Debt$ -38.74M$ -56.06M$ -47.75M$ -126.84M$ -117.07M
Total Liabilities$ 52.53M$ 51.42M$ 38.46M$ 48.59M$ 24.17M
Stockholders' Equity$ 180.01M$ 137.25M$ 126.48M$ 211.67M$ 208.21M
Cash Flow
Free Cash Flow$ -157.44M$ -100.67M$ -95.69M$ -100.99M$ -79.05M
Operating Cash Flow$ -156.29M$ -100.01M$ -94.18M$ -97.98M$ -77.76M
Investing Cash Flow$ -58.45M$ -16.09M$ 9.69M$ 59.16M$ -91.09M
Financing Cash Flow$ 194.45M$ 122.44M$ 3.12M$ 74.83M$ 134.99M
Currency in USD

Solid Biosciences Earnings and Revenue History

Income Statement >

Solid Biosciences Debt to Assets

Balance Sheet >

Solid Biosciences Cash Flow

Cash Flow >

Solid Biosciences Forecast EPS vs Actual EPS

Earnings >